These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9714245

  • 1. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
    Gill DK, Bible JM, Biswas C, Kell B, Best JM, Punchard NA, Cason J.
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
    [Abstract] [Full Text] [Related]

  • 2. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
    de Gruijl TD, Bontkes HJ, Stukart MJ, Walboomers JM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ.
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
    Tsukui T, Hildesheim A, Schiffman MH, Lucci J, Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu W, Marshall MA, Mann D, Carrington M, Clerici M, Shearer GM, Carbone DP, Scott DR, Houghten RA, Berzofsky JA.
    Cancer Res; 1996 Sep 01; 56(17):3967-74. PubMed ID: 8752165
    [Abstract] [Full Text] [Related]

  • 4. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CM, Williamson AL.
    J Med Virol; 2000 Apr 01; 60(4):403-10. PubMed ID: 10686023
    [Abstract] [Full Text] [Related]

  • 5. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH.
    J Natl Cancer Inst; 1997 Sep 03; 89(17):1285-93. PubMed ID: 9293919
    [Abstract] [Full Text] [Related]

  • 6. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals.
    Luxton JC, Rowe AJ, Cridland JC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1996 Jul 03; 77 ( Pt 7)():1585-93. PubMed ID: 8758003
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
    Bontkes HJ, de Gruijl TD, van den Muysenberg AJ, Verheijen RH, Stukart MJ, Meijer CJ, Scheper RJ, Stacey SN, Duggan-Keen MF, Stern PL, Man S, Borysiewicz LK, Walboomers JM.
    Int J Cancer; 2000 Oct 01; 88(1):92-8. PubMed ID: 10962445
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment.
    Luxton JC, Nath R, Derias N, Herbert A, Shepherd PS.
    J Gen Virol; 2003 May 01; 84(Pt 5):1063-1070. PubMed ID: 12692269
    [Abstract] [Full Text] [Related]

  • 9. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RH, Helmerhorst TJ, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.
    J Gen Virol; 1999 Feb 01; 80 ( Pt 2)():399-408. PubMed ID: 10073700
    [Abstract] [Full Text] [Related]

  • 10. Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions.
    Rocha-Zavaleta L, Ambrosio JP, Mora-Garcia ML, Cruz-Talonia F, Hernandez-Montes J, Weiss-Steider B, Ortiz-Navarrete V, Monroy-Garcia A.
    J Gen Virol; 2004 Sep 01; 85(Pt 9):2643-2650. PubMed ID: 15302958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
    Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ.
    J Gen Virol; 1999 Feb 01; 80 ( Pt 2)():409-417. PubMed ID: 10073701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions.
    Lee BN, Follen M, Rodriquez G, Shen DY, Malpica A, Shearer WT, Reuben JM.
    Cancer; 2006 Sep 01; 107(5):999-1007. PubMed ID: 16874820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D, Rose RC, Williamson AL.
    J Med Virol; 1997 Feb 01; 51(2):126-31. PubMed ID: 9021543
    [Abstract] [Full Text] [Related]

  • 17. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
    Zhou H, Schwartz MR, Coffey D, Smith D, Mody DR, Ge Y.
    Cancer Cytopathol; 2012 Dec 25; 120(6):373-9. PubMed ID: 22648956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1997 Apr 25; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.